Physician profile
Henry Jen
NPI 1487064390
$3,962.83
in general payments reported to CMS, 2019-2025
12 companies · $646 in 2025
The $646 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $133 · 2021: $1,530 · 2022: $605 · 2023: $455 · 2024: $593 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,694.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,620.69 | 2021-2022 | |
| Boston Scientific Corporation | $1,018.11 | 2021-2025 | Exalt Model D, Spyglass, Spyglass |
| Olympus America INC. | $493.75 | 2020-2025 | Single Use Aspiration Needle Na-U200h, Evis Exera III Colonovideoscope, Evis Exera II Ultrasound Gastrovideoscope |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.32 | 2021 | |
| Abbvie INC. | $134.62 | 2020-2023 | |
| Pentax of America, INC. | $120.14 | 2025 | Pentax Medical, C2 Cryoballoon Focal Controller, C2 Cryoballoon |
| Erbe USA INC | $100.00 | 2025 | Vio3 |
| Steris Corporation | $98.31 | 2024 | |
| Cook Medical LLC | $88.70 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $64.96 | 2024 | |
| Fujifilm Healthcare Americas Corporation | $37.58 | 2024 | |
| Janssen Biotech, INC. | $22.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Jen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.